Royce & Associates’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-24,250
Closed -$1.28M 852
2024
Q3
$1.28M Buy
24,250
+10,000
+70% +$528K 0.01% 694
2024
Q2
$772K Hold
14,250
0.01% 751
2024
Q1
$999K Buy
+14,250
New +$999K 0.01% 725
2014
Q2
Sell
-700,000
Closed -$6.65M 1426
2014
Q1
$6.65M Buy
+700,000
New +$6.65M 0.02% 802